Esperion Therapeutics
ESPR
#6758
Rank
NZ$1.40 B
Marketcap
NZ$5.44
Share price
0.00%
Change (1 day)
33.05%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2026 (TTM): NZ$0.13 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.41 Billion. In 2025 the company made an earning of NZ$0.10 Billion, an increase over its 2024 earnings that were of NZ$12.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.13 B25.04%
2025 NZ$0.10 B749.49%
2024 NZ$12.83 M-104.99%
2023 -NZ$0.26 Billion-15.03%
2022 -NZ$0.31 Billion-20.61%
2021 -NZ$0.39 Billion84.28%
2020 -NZ$0.21 Billion35.75%
2019 -NZ$0.16 Billion-55.71%
2018 -NZ$0.35 Billion19.57%
2017 -NZ$0.29 Billion125.39%
2016 -NZ$0.13 Billion51.43%
2015 -NZ$84.27 Million36.45%
2014 -NZ$61.76 Million43.55%
2013 -NZ$43.03 Million145.26%
2012 -NZ$17.55 Million
2002 -NZ$50.01 Million-7.81%
2001 -NZ$54.25 Million15.03%
2000 -NZ$47.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.11 B 13,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.82 B 6,395.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.92 Billion-775.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$44.63 Million-132.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.32 M-99.76%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B 385.70%๐Ÿ‡บ๐Ÿ‡ธ USA